Find your path to Roland
165 people in our graph share verified history with Roland — schools, employers, funds. One of them is your warm intro.
Yibo NianunlockedRoland: together at University of California, Berkeley, Haas School of Business (2011)
×9Roland: together at University of California, Berkeley, Haas School of Business
Roland: together at Theravance Biopharma
Roland: together at Bluejay Therapeutics
About
Roland Gendron is Chief Business Officer at Stipple Bio, where he leads corporate and business development, strategic partnerships, alliance management, and corporate strategy in support of therapies for difficult-to-treat cancers. He has more than 25 years of pharmaceutical industry experience spanning corporate and business development, commercial strategy, alliance management, and research and development. His areas of focus include R&D finance, marketing research, competitive intelligence, and negotiations.
Chief Business Officer at Stipple Bio
Intro paths
→
In turn, Roland can intro founders to Stipple Bio's investors below.
Stipple Bio's investors · 8
Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2026Axial VCSan Francisco · $100K – $5M checksGV (Google Ventures)Mountain View · $250K – $50M checks · since 2026LoLa Capital PartnersBoston · since 2026Magnetic VenturesBoston · $1M – $6M checksNextech InvestZurich · $648K – $3.2M checks · since 2026OMX VenturesLincolnshireRA CapitalBoston · since 2026
Co-founders at Stipple Bio
AR
Aaron RingCo-founder
AM
Aashish ManglikCo-founder
Experience
- Stipple BioChief Business Officercurrent2026 — presentGreater Seattle Area
- Merus N.V.SVP, Head of Business Development and Alliance Management2025 — 2026Cambridge, Massachusetts, United States
- Bluejay TherapeuticsSVP, Head of Business Development2024 — 2025San Mateo County, California, United States
- Gilead SciencesHead, Oncology Corporate Development2022 — 2024
- CytomX TherapeuticsVice President, Business Development2021 — 2022
- SeagenSenior Director of Corporate Development2020 — 2021
- SeagenDirector of Corporate Development2018 — 2020
- SeagenAssociate Director, Business Development2016 — 2018
- Raptor PharmaceuticalsAssociate Director, Global Strategy and Analytics2015 — 2016
- Theravance Biopharma, Inc.Senior Manager, Commercial & Strategic Planning2015
- Theravance Biopharma, Inc.Manager, Commercial & Strategic Planning2013 — 2015
- Theravance Biopharma, Inc.Senior Business Development Associate2012 — 2013
- Theravance Biopharma, Inc.Senior Financial Analyst2011 — 2012
- Theravance Biopharma, Inc.Scientist2011
- Theravance Inc.Associate Scientist2008 — 2010
- TheravanceSenior Research Associate2006 — 2008
- Theravance Inc.Research Associate2004 — 2006
- University of VictoriaGraduate Student - w/ David J Berg1999 — 2001
Skills & more
Research6Competitive Intelligence8Life Sciences19Biotechnology44Data Analysis10Budgeting1Drug Discovery18Lifesciences13Clinical Trials4Budgets1Clinical Development11R&D8
+9 more
CommercializationBiopharmaceuticalsCross-functional Team LeadershipBusiness DevelopmentNegotiationStrategic PlanningCROStrategyPharmaceutical IndustryFrom Roland's professional profile.
Frequently asked questions
- Who is Roland Gendron?
- Roland Gendron is Chief Business Officer at Stipple Bio, where he leads corporate and business development, strategic partnerships, alliance management, and corporate strategy in support of therapies for difficult-to-treat cancers. He has more than 25 years of pharmaceutical industry experience spanning corporate and business development, commercial strategy, alliance management, and research and development. His areas of focus include R&D finance, marketing research, competitive intelligence, and negotiations.
- Where does Roland Gendron work?
- Roland Gendron is Chief Business Officer at Stipple Bio.
- Where did Roland Gendron go to school?
- Roland Gendron studied at University of California, Berkeley, Haas School of Business (MBA, Emphasis on Life Sciences); University of Victoria (Master of Science, Chemistry); University of Victoria (Bachelor of Science, Chemistry).
Same school
Also attended University of California, Berkeley, Haas School of Business974
Mark FiorentinoInvestor at Index VenturesRishi ModiInvestor at GV (Google Ventures)Yibo NianInvestment Director at Intel CapitalZhenyu TangInvestment Director at Intel CapitalDennisDirector of Trading at Pantera CapitalAnna ChenInvestor at Madrona Venture Group
+ 968 more
Also attended University of Victoria138
Stewart ButterfieldCo-founder of Slack and FlickrDana OshiroPartner at HeavybitSandra MalmbergInvestor at EQT VenturesRafael BirnbaumVice President at TCVMitchell BallentineMarketing at Pangaea Ventures Us Inc.Aaron FykeFounder and Managing Partner at Thin Line Capital
+ 132 more
Also attended University of Cambridge1,600
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosFounder and Managing Partner of VerdictGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
+ 1,594 more
Shared employers
Also worked at Merus N.V.8
Shelley MargetsonManaging Partner at V-Bio VenturesJack NielsenManaging Partner at Vivo CapitalJohn de KoningPartner at EQT Life SciencesDr. Jeanne BolgerAdvisor at Apollo Health VenturesHui LiuExecutive Officer at MerusJohn CrowleyExecutive Officer at Merus
+ 2 more
Also worked at Gilead Sciences55
Uri LopatinInvestor at Khosla VenturesJay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLaura QuockCBO-in-Residence at Versant VenturesLan WuAnalyst at FusionKate ButlerInvestor at Syncona
+ 49 more
Also worked at CytomX Therapeutics12
Bryan A. IrvingSenior Advisor at Frazier Life SciencesCharles (Charlie) FuchsSenior Advisor at Frazier Life SciencesKrishna PoluPrincipal at Red Tree VentureJeff LandauChief Executive Officer at Stipple BioRachel HumphreyFounding Chief Executive Officer at NormunitySean McCarthyExecutive Officer, Director at CytomX Therapeutics
+ 6 more
Also worked at Seagen8
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Doug WilliamsBiotech Executive & Founding Pillar at Pillar VCLouis BockVenture Partner at Sante VenturesDr. Guy PadburySVP, Oncology Clinical Pharmacology at Illinois VenturesNeela PatelExecutive Officer at Bonum TherapeuticsTed W. LoveExecutive Officer, Director at Global Blood Therapeutics
+ 2 more